Anti-fibrotic agent therapy(Boehringer Ingelheim)

N/A

Report date: 2024/05/20 15:49:22

Base Information

Drug NameAnti-fibrotic agent therapy(Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesHeart DiseasesKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesHeart DiseasesKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A